Applying AI-Driven Biosimulation to Drug Discovery
Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…
Certara2026 年 6 月 2 日
Oxford Academic, Neuro-Oncology Pediatrics – BRAF pub: Growth recovery in patients with BRAF-altered pediatric low-grade glioma following treatment with tovorafenib
This publication reports a pooled retrospective analysis evaluating growth patterns in children with B-Raf proto-oncogene…
Dorottya Gui-Bodnar2026 年 5 月 28 日
The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators
Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…
Certara2026 年 5 月 26 日
Certainty US 2026 recap: Advancing model-informed drug development right from the start
This blog shares the highlights of our US Certainty event and explains how AI-enabled approaches…
Certara2026 年 5 月 26 日
Population Pharmacokinetic Modeling of Niraparib to Assess Different Absorption Models
This publication describes the development of an updated population pharmacokinetic (PopPK) model for niraparib, a…
Certara2026 年 5 月 21 日
Quantitative Systems Pharmacology Modeling of Atopic Dermatitis to Predict Biologic Therapy Response
Quantitative Systems Pharmacology Modeling of Atopic Dermatitis to Predict Biologic Therapy Response
Explore a quantitative systems pharmacology (QSP) model of atopic dermatitis calibrated to clinical trial data.
Certara2026 年 5 月 21 日
How to Leverage PBPK Modeling and Simulation in Drug Research and Development
Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…
Certara2026 年 5 月 12 日
Predicting FcRn-Mediated PK/PD with PBPK Modeling
Learn how PBPK modeling predicts FcRn binder PK/PD and IgG dynamics across species.
Certara2026 年 5 月 12 日
Predicting Ocular Drug Behavior with PBPK Modeling
Learn how PBPK modeling predicts ocular drug exposure and target occupancy to optimize anti-VEGF therapies…
Certara2026 年 5 月 12 日
Advancing In Vivo CAR-T with QSP
Learn how QSP modeling improves first-in-human dose selection for CAR-T therapies, enabling better translation and…
Certara2026 年 5 月 12 日
